NO159698C - Fremgangsm te til pasteurisering av human-fibrinoge - Google Patents

Fremgangsm te til pasteurisering av human-fibrinoge

Info

Publication number
NO159698C
NO159698C NO832977A NO832977A NO159698C NO 159698 C NO159698 C NO 159698C NO 832977 A NO832977 A NO 832977A NO 832977 A NO832977 A NO 832977A NO 159698 C NO159698 C NO 159698C
Authority
NO
Norway
Prior art keywords
pasteurization
human
fibrinoge
procedure
human fibrinogen
Prior art date
Application number
NO832977A
Other languages
English (en)
Norwegian (no)
Other versions
NO159698B (no
NO832977L (no
Inventor
Gerhardt Kumpe
Wilfried Wormsbaecher
Norbert Heimburger
Peter Fuhge
Hans Martin Preis
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6171221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO159698(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO832977L publication Critical patent/NO832977L/no
Publication of NO159698B publication Critical patent/NO159698B/no
Publication of NO159698C publication Critical patent/NO159698C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
  • Ceramic Capacitors (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Peptides Or Proteins (AREA)
NO832977A 1982-08-19 1983-08-18 Fremgangsm te til pasteurisering av human-fibrinoge NO159698C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3230849A DE3230849A1 (de) 1982-08-19 1982-08-19 Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung

Publications (3)

Publication Number Publication Date
NO832977L NO832977L (no) 1984-02-20
NO159698B NO159698B (no) 1988-10-24
NO159698C true NO159698C (no) 1989-02-01

Family

ID=6171221

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832977A NO159698C (no) 1982-08-19 1983-08-18 Fremgangsm te til pasteurisering av human-fibrinoge

Country Status (14)

Country Link
US (1) US4960757A (es)
EP (1) EP0103196B2 (es)
JP (1) JPH0694419B2 (es)
AT (1) ATE47525T1 (es)
AU (1) AU587365B2 (es)
CA (1) CA1203166A (es)
DE (2) DE3230849A1 (es)
ES (1) ES524992A0 (es)
GR (1) GR78934B (es)
IL (1) IL69515A (es)
NO (1) NO159698C (es)
NZ (1) NZ205306A (es)
PT (1) PT77213B (es)
ZA (1) ZA836093B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
JP2526073B2 (ja) * 1987-10-06 1996-08-21 株式会社ミドリ十字 異常破水治療剤
AT407834B (de) * 1987-10-08 2001-06-25 Aventis Behring Gmbh Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
FR2650508A1 (fr) 1989-08-01 1991-02-08 Fondation Nale Transfusion San Colle pasteurisee pour reunir des tissus humain ou animal
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
DE4202667C1 (es) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
FR2687317B1 (fr) * 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
AU4693093A (en) * 1992-07-27 1994-02-14 Haemacure Biotech Inc. Biocompatible surgical implant
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
CA2185228A1 (en) * 1994-03-31 1995-10-12 John F. Lontz Cryoprecipitated native fibrinogen concentrates
JP5149470B2 (ja) 1999-02-22 2013-02-20 バクスター・インターナショナル・インコーポレイテッド 新規のアルブミンを含有していない第ｖｉｉｉ因子処方物
US6916911B1 (en) 1999-08-13 2005-07-12 Omrix Biopharmaceuticals Sa Use of fibrinogen multimers
WO2001012244A1 (en) * 1999-08-13 2001-02-22 Omrix Biopharmaceuticals S.A. Use of fibrinogen multimers
EP1240200B1 (en) * 1999-12-23 2009-06-03 Csl Limited Separation of fibrinogen from plasma proteases
JP4733283B2 (ja) * 2000-03-28 2011-07-27 一般財団法人化学及血清療法研究所 液状フィブリノゲン製剤
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
DE10261126A1 (de) 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
DE102004037805B3 (de) * 2004-08-03 2006-03-23 Zlb Behring Gmbh Verfahren zur Hitzebehandlung fibrinogenhaltiger pharmazeutischer Zubereitungen
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
RU2556804C2 (ru) * 2013-12-17 2015-07-20 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения РФ Способ получения концентрата фибриногена

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate

Also Published As

Publication number Publication date
JPS5953428A (ja) 1984-03-28
NZ205306A (en) 1987-02-20
JPH0694419B2 (ja) 1994-11-24
DE3380764D1 (en) 1989-11-30
AU1810983A (en) 1984-02-23
NO159698B (no) 1988-10-24
GR78934B (es) 1984-10-02
EP0103196B1 (de) 1989-10-25
IL69515A0 (en) 1983-11-30
ES8506450A1 (es) 1985-08-01
EP0103196A2 (de) 1984-03-21
CA1203166A (en) 1986-04-15
AU587365B2 (en) 1989-08-17
PT77213B (de) 1986-03-18
PT77213A (de) 1983-09-01
EP0103196A3 (en) 1985-05-08
US4960757A (en) 1990-10-02
ATE47525T1 (de) 1989-11-15
ZA836093B (en) 1984-04-25
IL69515A (en) 1987-01-30
NO832977L (no) 1984-02-20
DE3230849A1 (de) 1984-02-23
EP0103196B2 (de) 1994-10-12
ES524992A0 (es) 1985-08-01

Similar Documents

Publication Publication Date Title
NO159698C (no) Fremgangsm te til pasteurisering av human-fibrinoge
FI863703A (fi) Glykocidderivat.
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
JPS5794280A (en) Sterilizing treatment of package material with steam
ES526330A0 (es) Procedimiento para pasteurizar un crioprecipitado antihemofilico
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
IT1224144B (it) Procedimento per il trattamento dei tessili
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
NO921223L (no) Kombinasjonspreparat med antitrombotisk virkning
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DK162095C (da) Fremgangsmaade til fremstilling af thiotetronsyre
ATE43342T1 (de) Verfahren zur herstellung von hydrogeno- oder halogenosilanen.
ES2059323T3 (es) Procedimiento para la produccion de una preparacion de inmunoglobulina pasteurizada.
SE7608149L (sv) Sett att framstella texturerat protein
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
BG50298A1 (en) Composition and metohd for improving the output of tomato seeds
EP0302799A3 (en) Process for the preparation of l,l or d,d or racemic n6-benzyloxycarbonyl-2,6-diamino-pimelamic acid
DE3688742D1 (de) 2,2-diphenoxy-n,n-dimethylaminoaethan zur verbesserung der sauerstoffversorgung des gehirns.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003